tradingkey.logo
tradingkey.logo
검색

Phibro Animal Health Corp

PAHC
관심 목록에 추가
33.140USD
+1.040+3.24%
종가 07/02, 13:00ET시세는 15분 지연됩니다
1.34B시가총액
14.11P/E TTM

Phibro Animal Health Corp

33.140
+1.040+3.24%

자세한 내용은 Phibro Animal Health Corp 회사

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.

Phibro Animal Health Corp 정보

종목 코드 PAHC
회사 이름Phibro Animal Health Corp
상장일Apr 11, 2014
CEOBendheim (Jack C)
직원 수2475
유형Ordinary Share
회계 연도 종료Apr 11
주소Glenpointe Centre East, 3Rd Floor
도시TEANECK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호07666
전화12013297300
웹사이트https://www.pahc.com/
종목 코드 PAHC
상장일Apr 11, 2014
CEOBendheim (Jack C)

Phibro Animal Health Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
41.24K
+24.25%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
47.47K
+36.80%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
41.24K
+24.25%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-17.28%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--

자주 묻는 질문

Phibro Animal Health Corp의 상위 5대 주주는 누구인가요?

Phibro Animal Health Corp의 상위 5대 주주는 다음과 같습니다: Mr. Glenn C. David

Phibro Animal Health Corp(PAHC)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Phibro Animal Health Corp의 주식을 보유한 기관은 총 474곳이며, 이들이 보유한 주식의 총 가치는 약 22.03M로 전체 발행 주식의 104.57%를 차지합니다. 이는 2025Q4 대비 -645505.00 증가한 수치입니다.

Phibro Animal Health Corp의 최대 수익원은 무엇인가요?

2026Q1 기준, Phibro Animal Health Corp의 MFAs and Other 부문이 가장 높은 매출을 기록했으며, 금액은 202.11M로 전체 매출의 54.05%를 차지했습니다.